Other investigations suggested that ST6Gal-I-mediated sialylation hampered binding of N-linked glycans to galectins, which are documented participants in various biological events including adhesion, angiogenesis, apoptosis, differentiation, inflammatory signaling, migration, survival, and tumor progression [55,56,57,58,59,60,61]. Here, ST6GAL1 is linked to neoplasm.